.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Medtronic
Federal Trade Commission
Boehringer Ingelheim
UBS
Harvard Business School
Cantor Fitzgerald
Accenture
Deloitte
Cipla
AstraZeneca

Generated: July 20, 2017

DrugPatentWatch Database Preview

Details for Patent: 4,894,220

« Back to Dashboard

Summary for Patent: 4,894,220

Title: Antibacterial antiplaque oral composition
Abstract:An oral composition such as a dentifrice or mouthwash, containing an aqueous phase of water and as solubilizing agent propylene glycol, dipropylene glycol, methyl cellosolve, ethyl cellosolve, olive oil, castor oil, amyl acetate, ethyl acetate, glyceryl tristearate or benzyl benzoate mixed with at least one of glycerine and sorbitol, a substantially water-insoluble noncationic antibacterial antiplaque agent, such as 2,4,4'-trichloro-2.sup.1 -hydroxydiphenyl ether (triclosan), and a synthetic anionic linear polymeric polycarboxylate having a molecular weight of about 1,000 to about 1,000,000.
Inventor(s): Nabi; Nuran (North Brunswick, NJ), Gaffar; Abdul (Princeton, NJ)
Assignee: Colgate-Palmolive Company (New York, NY)
Application Number:07/291,712
Patent Claim Types:
see list of patent claims
Composition; Compound;

No matches for this query

International Patent Family for Patent: 4,894,220

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Greece1002323► Subscribe
Greece890100853► Subscribe
Greece1004463► Subscribe
Hong Kong70497► Subscribe
China1049606► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Mallinckrodt
Merck
Novartis
Queensland Health
Argus Health
Accenture
Express Scripts
QuintilesIMS
Moodys
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot